Dingcong, Reymund C.
HRN: 22-45-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
CEFTRIAXONE 1G (VIAL)
01/05/2023
01/11/2023
IVT
2gms
Od
T/c Immunocompromised State Sec To Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes